← Leaderboards
Julie Chao
Medical University Of South Carolina
$9,369,252
Attributed
$9,369,252
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–17$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$9,369,252 · 9
By mechanism
R01$8,769,192 · 5
P20$600,060 · 4
Top collaborators
No co-investigators on record.
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- David A Baker$5,284,887
- Brent M Egan$2,811,640
- Donald R. Menick$17,263,987
- Ayad A Jaffa$7,063,873
- Eni C Okonofua$213,959
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisHuman TissueTissue /Cell CultureInflammationKidneyRattusBaseCardiovascular SystemMediatingSignal PathwayAnimal ModelGene ExpressionGene DeliveryCardiovascular DiseasesRepairedGenetically Modified AnimalsFunctional DisorderOxidative StressInjuryHypertensionFibrosisHypertrophyBlood VesselsNitric Oxide
Grant awards (35)
Kallistatin in Vascular Injury$373,750
R01 · FY2017 · HL · contact PI
Kallistatin in Vascular Injury$373,750
R01 · FY2016 · HL · contact PI
Kallistatin in Vascular Injury$368,144
R01 · FY2015 · HL · contact PI
Kallistatin in Vascular Injury$373,750
R01 · FY2014 · HL · contact PI
Regulation and Function of Tissue Kallikrein$365,063
R01 · FY2012 · HL · contact PI
Regulation and Function of Tissue Kallikrein$368,750
R01 · FY2011 · HL · contact PI
Regulation and Function of Tissue Kallikrein$368,750
R01 · FY2010 · HL · contact PI
Regulation and Function of Tissue Kallikrein$368,750
R01 · FY2009 · HL · contact PI
Regulation and Function of Tissue Kallikrein$51,373
R01 · FY2009 · HL · contact PI
Regulation and Function of Tissue Kallikrein$368,437
R01 · FY2008 · HL · contact PI
Kallistatin in Hypertension$276,869
R01 · FY2008 · HL · contact PI
Kallistatin in Hypertension$276,869
R01 · FY2007 · HL · contact PI
Tissue Kallikrein, Oxidative Stress and Renal Fibrosis$274,100
R01 · FY2007 · DK · contact PI
SC COBRE: PROTEIN SCIENCE CORE$176,624
P20 · FY2007 · RR · contact PI
Regulation and Function of Tissue Kallikrein$320,781
R01 · FY2006 · HL · contact PI
Kallistatin in Hypertension$285,138
R01 · FY2006 · HL · contact PI
Tissue Kallikrein, Oxidative Stress and Renal Fibrosis$282,287
R01 · FY2006 · DK · contact PI
SC COBRE: PROTEIN SCIENCE CORE$205,273
P20 · FY2006 · RR · contact PI
Regulation and Function of Tissue Kallikrein$328,500
R01 · FY2005 · HL
Kallistatin in Hypertension$292,000
R01 · FY2005 · HL
Tissue Kallikrein, Oxidative Stress and Renal Fibrosis$289,080
R01 · FY2005 · DK
SC COBRE: PROTEIN SCIENCE CORE$126,589
P20 · FY2005 · RR
Tissue Kallikrein, Oxidative Stress and Renal Fibrosis$289,080
R01 · FY2004 · DK
Regulation and Function of Tissue Kallikrein$200,405
R01 · FY2004 · HL
CORE--PROTEIN SCIENCE$91,574
P20 · FY2004 · RR
Regulation and Function of Tissue Kallikrein$328,500
R01 · FY2003 · HL
KALLISTATIN IN HYPERTENSION$248,962
R01 · FY2003 · HL
REGULATION AND FUNCTION OF RENAL KALLIKREIN$272,126
R01 · FY2002 · HL
KALLISTATIN IN HYPERTENSION$241,707
R01 · FY2002 · HL
CORE--PROTEIN SCIENCE$0
P20 · FY2002 · RR
REGULATION AND FUNCTION OF RENAL KALLIKREIN$264,201
R01 · FY2001 · HL
KALLISTATIN IN HYPERTENSION$234,665
R01 · FY2001 · HL
REGULATION AND FUNCTION OF RENAL KALLIKREIN$256,506
R01 · FY2000 · HL
KALLISTATIN IN HYPERTENSION$227,831
R01 · FY2000 · HL
BRADYKININ RECEPTORS IN HYPERTENSION$199,068
R01 · FY2000 · HL